Literature DB >> 30657582

Therapeutic uses of metronidazole and its side effects: an update.

A Hernández Ceruelos1, L C Romero-Quezada, J C Ruvalcaba Ledezma, L López Contreras.   

Abstract

OBJECTIVE: Metronidazole is an antibiotic widely used in different medical conditions such as trichomoniasis, amoebiasis, and giardiasis among others. Its use has been associated with toxicity; however, it is not well characterized. In this review, we discuss the different therapeutic uses of metronidazole and its side effects in order to aid future investigation in this field.
MATERIALS AND METHODS: Relevant information, original research articles, clinical trials, and reviews were collected from PubMed to know the state of the art of the different therapeutic uses of metronidazole and the reported side effects.
RESULTS: Metronidazole was used by the first time in 1959, to treat an infection caused by Trichomonas vaginalis; subsequently, new therapeutic properties were discovered. Nowadays, Metronidazole is used to treat infections caused by Bacteroides, Fusobacteria and Clostridia, rosacea, oral and dental infections, bone and joint infections, gynecologic infections, endocarditis, septicemia, and respiratory tract infections. It also can be used to treat Crohn´s disease or even like prophylaxis, before surgical procedures. Metronidazole is well tolerated with mild to moderate side effects such as nausea, abdominal pain, and diarrhea. Nevertheless, serious neurotoxicity, optic neuropathy, peripheral neuropathy, and encephalopathy have been reported in rare cases. Their genotoxic effects observed in animal models are controversial in humans.
CONCLUSIONS: The therapeutic use of metronidazole had increased worldwide. Even though it is widely used, metronidazole has been associated with neurotoxicity and genotoxicity; however, its side effects are not well established. Conversely, its veterinary use is restricted in some countries because of its tumor association. Subsequently, further studies are needed to discover the secure use of metronidazole and describe new usages for this drug.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30657582     DOI: 10.26355/eurrev_201901_16788

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  22 in total

1.  In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis.

Authors:  Taher Elmi; Bahman Rahimi Esboei; Fatemeh Sadeghi; Zahra Zamani; Mojtaba Didehdar; Mahdi Fakhar; Aroona Chabra; Fateme Hajialiani; Mohammad Javad Namazi; Fatemeh Tabatabaie
Journal:  Acta Parasitol       Date:  2020-07-14       Impact factor: 1.440

2.  Metronidazole Induced Cerebellar Toxicity: A Case Report.

Authors:  Shova Sapkota; Aliska Niroula; Rina Prajapati; Subhani Sharma; Krishna Dhungana
Journal:  JNMA J Nepal Med Assoc       Date:  2021-09-11       Impact factor: 0.556

3.  Metronidazole-Induced Irreversible Optic Neuropathy.

Authors:  Pai-Huei Peng; Tzu-En Wu; Ting-Yu Lin
Journal:  Case Rep Ophthalmol       Date:  2021-05-10

4.  Polyphenolic extract from Punica granatum peel causes cytoskeleton-related damage on Giardia lamblia trophozoites in vitro.

Authors:  Lissethe Palomo-Ligas; Job Estrada-Camacho; Mariana Garza-Ontiveros; José Roberto Vargas-Villanueva; Filiberto Gutiérrez-Gutiérrez; Sendar Daniel Nery-Flores; Jorge Arturo Cañas Montoya; Juan Ascacio-Valdés; Lizeth Guadalupe Campos-Muzquiz; Raul Rodriguez-Herrera
Journal:  PeerJ       Date:  2022-04-27       Impact factor: 3.061

Review 5.  Nitroaromatic Antibiotics as Nitrogen Oxide Sources.

Authors:  Allison M Rice; Yueming Long; S Bruce King
Journal:  Biomolecules       Date:  2021-02-12

6.  Encapsulation of Metronidazole in Biocompatible Macrocycles and Structural Characterization of Its Nano Spray-Dried Nanostructured Composite.

Authors:  Mirella Mirankó; Mónika Megyesi; Zsombor Miskolczy; Judit Tóth; Tivadar Feczkó; László Biczók
Journal:  Molecules       Date:  2021-12-02       Impact factor: 4.411

7.  Anti-inflammatory Effect of Metronidazole in Hospitalized Patients with Pneumonia due to COVID-19.

Authors:  Muhanna Kazempour; Hossein Izadi; Arezoo Chouhdari; Morteza Rezaeifard
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

8.  Bone and joint infections caused by Clostridium perfringens: a case series.

Authors:  Margaux Visse; Véronique Vernet-Garnier; Odile Bajolet; Delphine Lebrun; Morgane Bonnet; Maxime Hentzien; Xavier Ohl; Saidou Diallo; Firouzé Bani-Sadr
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-03-16       Impact factor: 3.267

9.  Antimicrobial prescriptions and adherence to prudent use guidelines for selected canine diseases in Switzerland in 2016.

Authors:  Bérénice Lutz; Claudia Lehner; Kira Schmitt; Barbara Willi; Gertraud Schüpbach; Meike Mevissen; Ruth Peter; Cedric Müntener; Hanspeter Naegeli; Simone Schuller
Journal:  Vet Rec Open       Date:  2020-03-09

10.  The effectiveness of rotating versus single course antibiotics for small intestinal bacterial overgrowth.

Authors:  Nicolas Richard; Charlotte Desprez; Fabien Wuestenberghs; Anne-Marie Leroi; Guillaume Gourcerol; Chloé Melchior
Journal:  United European Gastroenterol J       Date:  2021-07-09       Impact factor: 4.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.